Who Owns BRNS?

Barinthus Biotherapeutics plc — Institutional Ownership & 13F Holdings

$0.64

-0.00 (-0.47%)

Market Cap

$22.9M

Shares Outstanding

40,848,893

Institutional Holders

15

Total Inst. Value

$9.1M

% of Float Held

QoQ Holder Change

+2

Institutional data as of Q1 2025

New Positions

4

Closed Positions

4

Increased

1

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1M&G Plc$5.2M5,197,349
2Alphabet Inc.$1.5M1,513,644
3HSG Holding Ltd$1.2M1,420,473
4DC Funds, LP$625K642,204
5GILEAD SCIENCES, INC.$360K369,855
6Johns Hopkins University$119K122,237
7Baird Financial Group, Inc.$90K92,461
8HighTower Advisors, LLCNew$36K37,450
9RENAISSANCE TECHNOLOGIES LLC$35K35,700
10CITADEL ADVISORS LLCNew$26K26,172

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold BRNS?

As of Q1 2025, 15 institutional investors report holding BRNS (Barinthus Biotherapeutics plc) in their 13F filings.

Which hedge fund owns the most BRNS?

The largest institutional holder of BRNS is M&G Plc with $5.2M in shares.

Are institutions buying or selling BRNS?

This quarter, 4 institutions opened new positions in BRNS and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.